Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 12, 2026 FORM 4
144 Jun 12, 2026
144 Jun 10, 2026
8-K Jun 3, 2026 8-K
424B5 Jun 3, 2026 424B5
8-K Jun 3, 2026 8-K
8-K May 22, 2026 8-K
4 May 19, 2026 FORM 4
144 May 18, 2026
4 May 13, 2026 FORM 4
144 May 13, 2026
144 May 12, 2026
144 May 11, 2026
10-Q May 6, 2026 10-Q
8-K May 6, 2026 8-K
4 Apr 21, 2026 FORM 4
144 Apr 17, 2026
4 Apr 15, 2026 FORM 4
4 Apr 15, 2026 FORM 4
144 Apr 15, 2026
4 Apr 13, 2026 FORM 4
144 Apr 13, 2026
144 Apr 13, 2026
ARS Apr 10, 2026 ARS
144 Apr 9, 2026
← Newer Page 3 of 17 · 406 filings Older →